Soligenix, Inc.
corporate_fare Company Profile
Soligenix, Inc. (NASDAQ:SNGX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for SNGX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- HyBryte Study Shows 60% Success in CTCL, Outperforming Comparator with Favorable Safety
- Soligenix Issues Going Concern Warning Amidst Mounting Losses and Zero Revenue for 2025
- EU Grants Orphan Drug Designation to Soligenix's Dusquetide for Behçet Disease
- UK Grants Soligenix's SGX945 'Promising Innovative Medicine' Status for Behçet Disease
- CEO Provides Positive Clinical & Financial Update, Confirms Cash Runway Through 2026
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$11.08M
Diluted EPS
-$2.14
Op. Cash Flow
-$10.27M
Operating Income
-$11.85M
Cash & Equivalents
$7.94M
Debt / Equity
0.00×
Shares Outstanding
10.09M sh
Source: 10-K · filed 2026-03-31 · accession 0001104659-26-037701
show_chartPrice Chart
Loading chart...
feed SNGX - Filings & News (Page 2)
SNGX
Apr 02, 2026, 10:56 AM EDT
Price at Filing:
$1.15
Real-time Price:
$0.2192
Change:
-$0.9308 (-81%)
Market Cap:
$5.143M
SNGX
Mar 31, 2026, 4:05 PM EDT
Price at Filing:
$1.15
Real-time Price:
$0.2192
Change:
-$0.9318 (-81%)
Market Cap:
$5.143M
SNGX
Mar 26, 2026, 11:46 AM EDT
Price at Filing:
$1.15
Real-time Price:
$0.2192
Change:
-$0.9258 (-81%)
Market Cap:
$5.143M
SNGX
Mar 10, 2026, 11:45 AM EDT
Price at Filing:
$1.20
Real-time Price:
$0.2192
Change:
-$0.9808 (-82%)
Market Cap:
$5.143M
SNGX
Feb 12, 2026, 4:05 PM EST
Price at Filing:
$1.06
Real-time Price:
$0.2192
Change:
-$0.8408 (-79%)
Market Cap:
$5.143M
SNGX
Jan 23, 2026, 4:31 PM EST
Price at Filing:
$1.37
Real-time Price:
$0.2192
Change:
-$1.15 (-84%)
Market Cap:
$5.143M
SNGX
Jan 23, 2026, 4:05 PM EST
Price at Filing:
$1.38
Real-time Price:
$0.2192
Change:
-$1.16 (-84%)
Market Cap:
$5.143M